DRAFT as of August 4, 2025
2025 Asian Myeloma Network 9th Annual Summit Hilton Hotel, Nagoya, Japan 16-19 October 2025
Thursday, October 16 18:00 – 20:00
Welcome Reception
Wee Joo Chng, Shinsuke Iida
Friday 17, October 07:00 – 09:00
Registration
09:00 – 09:10
Opening of 9th AMN Summit
Wee Joo Chng, Shinsuke Iida
Blood Based Diagnosis & Monitoring
Andrew Spencer
Keynote Address 09:10 – 09:40
Session 1
Optimal Frontline Treatment Multiple Myeloma
Session Chairs:
Kazuyuki Shimizu, Wenming Chen
09:40 – 09:55
Newly Diagnosed TE Optimal Treatment in 2026
Junling Zhuang
09:55 – 10:10
Newly Diagnosed TIE Optimal Treatment in 2026 Ja Min Byun
10:10 – 10:50
Panel Discussion with Q&A Session Panelists: Dok Hyun Yoon, Yeow Tee Goh, Chutima Kunacheewa, Chieh-Lin Teng
10:50 – 11:20
Coffee Break
1
Session 2
Mass Spectrometry
Session Chairs:
Jin Seok Kim, Masahiro Abe
11:20 – 11:35
Lessons from the Mayo Clinic
S. Vincent Rajkumar
11:35 – 11:50
Disease Monitoring/MRD
Hiroyuki Takamatsu
11:50 – 12:30
Panel Discussion with Q&A Session Panelists: Chengcheng Fu, Pankaj Malhotra, Beatrice Tiangoo, Sanjay de Mel
12:30 – 14:30
Lunch Symposia Sponsored by Sanofi
Session 3
Immune Therapy
Session Chairs:
James Chim, Panisinee Lawasut
14:30 – 14:45
CAR-T Real World Data
14:45 – 15:00
Incorporation and Optimal Use of BsAB in RRMM Chandramouli Nagarajan
15:00 – 15:40
Panel Discussion with Q&A Session Panelists: Juan Du, Je-Jung Lee, Shuji Ozaki, Uday Yanamandra
15:40 – 16:00
Coffee Break
Session 4
Immune Therapy (cont)
Session Chairs:
Gin Gin Gan, Jeffrey Huang
16:00 – 16:15
Resistance Mechanisms to BCMA Directed Therapies (CAR-T and BsAB) Wee Joo Chng Managing Post-BCMA Therapy Relapse (CAR-T and BsAB) Mohamad Mothy Panel Discussion with Q&A Session Panelists: Kazuhito Suzuki, Alison Tso, Flordeluna Messina, Do Huyen Nga
16:15 – 16:30 16:30 – 17:10 17:10
Close of Session
19:00 – 2100
Dinner
Jin Lu
Wee Joo Chng, Shinsuke Iida
2
Saturday, October 18 09:00 – 09:10
Opening of the Session
Wee Joo Chng, Shinsuke Iida
Session 5
Novel Treatments
Session Chairs:
Chandramouli Nagarajan, Priscilla Caguioa
09:10 – 09:25
CELMODS
Shaji Kumar
09:25 – 09:40
Novel Non-BCMA immunotherapies
Thomas Martin
09:40 – 10:30
Panel Discussion with Q&A Session Panelists: Weijun Fu, Ekarat Rattarittamrong, Sung Soo Yoon, Junya Kuroda Coffee Break
10:30 – 10:50
Session 6
Other Plasma Cell Disorders
Session Chairs: Kihyun Kim, Rosalio Torres 10:50 – 11:05
Critical Issues in Amyloidosis
Hiroshi Handa
11:05 – 11:20
Plasma Cell Leukemia
Sung Hoon Jung
11:20 – 12:00
Panel Discussion with Q&A Session Panelists: Wen Gao, Panisinee Lawasut, Karen Tang, Yun Xin Chen
12:00 – 12:15 12:15 – 14:15
Working Group Arrangements & Close of Morning Session Lunch Symposium Sponsored by Pfizer
Session 7
AMN Summit Working Groups Sessions
Daniel Navid
14:15 – 16:15 Infection and Side Effects Immunotherapy New AMN Research Resource Stratified Treatment Guidelines 16:15
James Chim & Jeffrey Huang Shinsuke Iida & Juan Du Kihyun Kim & Wee Joo Chng Daryl Tan & Uday Yanamandra
Day 2 Meeting Adjourn 3
19:00 - 22:00
2025 AMN Summit Award Dinner
09:00 -09:10
Opening of the Session
Session 8
Reports
Session Chairs:
Jian Hou, Sen Mui Tan
Sunday, October 19
Wee Joo Chng, Shinsuke Iida
Working Group Reports 09:10 – 09:30 09:30 – 09:50
Infection and Side Effects Immunotherapy
James Chim & Jeffrey Huang Shinsuke Iida & Juan Du
09:50 – 10:10 10:10 - 10:30 10:30 – 10:50
New AMN Research Kihyun Kim & Wee Joo Chng Resource Stratified Treatment Guidelines Daryl Tan & Uday Yanamandra Coffee Break
10:50 – 11:05
Status AMN Clinical Trials
Chandramouli Nagarajan & Kihyun Kim
11:05 – 11:20
Status AMN Tissue Bank
Wee Joo Chng & Hiroshi Handa
Session 9
Looking Ahead
Session Chairs:
Daryl Tan, Hiroshi Handa
11:20 – 11:50
Discussion on Future Direction AMN
11:50 – 12:00
Meeting Conclusions
Wee Joo Chng, and Shinsuke Iida
12:00
Summit Adjournment
Daniel Navid
4